BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22715473)

  • 1. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality.
    Drenger B; Fontes ML; Miao Y; Mathew JP; Gozal Y; Aronson S; Dietzel C; Mangano DT; ;
    Circulation; 2012 Jul; 126(3):261-9. PubMed ID: 22715473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which patients should be on renin-angiotensin system blockers after coronary surgery?
    Alassar A; Bazerbashi S; Easto R; Unsworth-White J
    Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):667-72. PubMed ID: 24997188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.
    Miceli A; Capoun R; Fino C; Narayan P; Bryan AJ; Angelini GD; Caputo M
    J Am Coll Cardiol; 2009 Nov; 54(19):1778-84. PubMed ID: 19682819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease.
    Mack MJ; Pfister A; Bachand D; Emery R; Magee MJ; Connolly M; Subramanian V
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):167-73. PubMed ID: 14752427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
    Kalavrouziotis D; Buth KJ; Cox JL; Baskett RJ
    Am Heart J; 2011 Nov; 162(5):836-43. PubMed ID: 22093199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery.
    Ouzounian M; Buth KJ; Valeeva L; Morton CC; Hassan A; Ali IS
    Ann Thorac Surg; 2012 Feb; 93(2):559-64. PubMed ID: 22269723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency.
    Tolpin DA; Collard CD; Lee VV; Elayda MA; Pan W
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):873-9. PubMed ID: 19660351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery.
    Ouattara A; Benhaoua H; Le Manach Y; Mabrouk-Zerguini N; Itani O; Osman A; Landi M; Riou B; Coriat P
    J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):633-8. PubMed ID: 19362495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-pump versus off-pump coronary artery bypass surgery in high-risk patients: operative results of a prospective randomized trial (on-off study).
    Lemma MG; Coscioni E; Tritto FP; Centofanti P; Fondacone C; Salica A; Rossi A; De Santo T; Di Benedetto G; Piazza L; Rinaldi M; Schinosa AL; De Paulis R; Contino M; Genoni M
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):625-31. PubMed ID: 22154798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery.
    Székely A; Levin J; Miao Y; Tudor IC; Vuylsteke A; Ofner P; Mangano DT;
    J Thorac Cardiovasc Surg; 2011 Aug; 142(2):430-7.e1. PubMed ID: 21497835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
    Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
    Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease.
    Sharony R; Grossi EA; Saunders PC; Galloway AC; Applebaum R; Ribakove GH; Culliford AT; Kanchuger M; Kronzon I; Colvin SB
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):406-13. PubMed ID: 14762348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting.
    Bandeali SJ; Kayani WT; Lee VV; Pan W; Elayda MA; Nambi V; Jneid HM; Alam M; Wilson JM; Birnbaum Y; Ballantyne CM; Virani SS
    Am J Cardiol; 2012 Oct; 110(7):919-23. PubMed ID: 22727178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of nonelective coronary revascularization with and without cardiopulmonary bypass.
    Stamou SC; Hill PC; Haile E; Prince S; Mack MJ; Corso PJ
    J Thorac Cardiovasc Surg; 2006 Jan; 131(1):28-33. PubMed ID: 16399291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.